Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 314-319

  Brisco, M J ^a   Sykes, P J ^a   Hughes, E ^a   Dolman, G ^a   Neoh, S H ^a   Peng, L M ^b   Toogood, I ^c   Morley, A A ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b SICHUAN UNIVERSITY   (China)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Acute lymphoblastic leukaemia; Blood; Minimal residual neoplasm; Peripheral circulation; Quantification

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CHILDHOOD CANCER; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PERIPHERAL CIRCULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030663383     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3723186.x     Document Type: Article

References (22)

1. Beishuizen, A., Verhoeven, M-A.J., Hahlen, K., van Wering, E.R. & van Dongen, J. (1992) Differences in immunoglobulin heavy chain gene rearrangment patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukemia at diagnosis. Leukemia, 6, 60-63.
2. Biondi, A., Yokota, S., Hansen-Hagge, T.E., Rossi, V., Giudici, G., Maglia, O., Basso, G., Tell, C., Masera, G. & Bartram, C.R. (1992) Minimal residual disease in childhood ALL: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia, 6, 282-288.
3. Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. & Morley, A.A. (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 343, 196-200.
4. Brisco, M.J., Hughes, E., Neoh, S.H., Sykes, P.J., Bradstock, K., Enno, A., Szer, J., McCaul, K. & Morley, A.A. (1996) Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood, 87, 5251-5256.
5. Brisco, M.J., Tan, L.W., Orsborn, A.M. & Morley, A.A. (1990) Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. British Journal of Haematology, 75, 163-167.
6. Cave, H., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneteau, O., Monplaisir, N., d'Auriol, L., Elion, J., Vilmer, E. & Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and γ T cell receptors. Blood, 83, 1892-1902.
7. d'Auriol, L., Macintyre, E., Galibert, F. & Sigaux, F. (1989) In vitro amplification of T cell γ gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. Leukemia, 3, 155-158.
8. Hansen-Hagge, T.E., Yokota, S. & Bartram, C.R. (1989) Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor δ chain sequences. Blood, 74, 1762-1767.
9. Izraeli, S., Janssen, J.W.G., Haas, O.A., Harbott, J., Brok-Simoni, F., Walther, J.U., Kovar, H., Henn, T., Ludwig, W-D., Reiter, A., Rechavi, G., Bartram, C.R., Gadner, H. & Lion, T. (1993) Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia, 7, 671-678.
10. Jonsson, O.G., Kitchens, R.L., Scott, F.C. & Smith, R.G. (1990) Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood, 76, 2072-2079.
11. Martin, H., Atta, J., Bruecher, J., Elsner, S., Schardt, C., Stadler, M., von-Melchner, H. & Hoelzer, D. (1994) In patients with BCR-ABL positive ALL in CR peripheral blood contains less residual disease than bone marrow: implications for autologous BMT. Annals of Hematology, 68, 85-87.
12. Nizet, Y., Martiat, P., Vaerman, J.L., Philippe, M., Wildmann, C., Staelens, J.P., Cornu, G., Ferrant, A., Michaux, J.L. & Sokal, G. (1991) Follow-up of residual disease (MRD) in B lineage acute leukaemias using a simplified PCR strategy: evolution of MRD rather than its detection is correlated with clinical outcome. British Journal of Haematology, 79, 205-210.
13. Nizet, Y. Van Daele, P., Lewalle, P., Vaerman, J.L., Philippe, M., Vermylen, C., Cornu, G., Ferrant, A., Michaux, J.L. & Martial, P. (1993) Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood, 82, 1618-1625.
14. Steenbergen, E.J., Verhagen, O.J.H.M., van Leeuwen, E.F., van den Berg, H., Behrendt, H., Slater, R.M., von dem Borne, A.E.G. & van der Schoot, C.E. (1995) Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia, 9, 1726-1734.
15. Sykes, P.J. & Morley, A.A. (1995) Limiting dilution polymerase chain reaction. Reverse Transcriptase PCR (ed. by J. W. Larrick and P. D. Siebert), pp. 150-165. Ellis Horwood, Chichester.
16. Sykes, P.J., Neoh, S.H., Brisco, M.J., Hughes, E., Condon, J. & Morley, A.A (1992) Quantitation of targets for the PCR by use of limiting dilution. Biotechniques, 13, 444-448.
17. Tycko, B., Palmer, J.D., Link, M.P., Smith, S.D. & Sklar, J. (1989) Polymerase chain reaction amplification of rearranged antigen receptor genes using junction-specific oligonucleotides: possible application for detection of minimal residual disease in acute lymphoblastic leukemia. Cancer Cells, 7, 47.
18. van Dongen, J.J.M., Breit, T.M., Adriaansen, H.J., Beishuizen, A. & Hooijkaas, H. (1992) Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia, 6, (Suppl. 1), 47-59.
19. van Rhee, F. Marks, D.I., Lin, F., Szydlo, R.M., Hochhaus, A., Treleaven, J., Delord, C., Cross, N.C.P. & Goldman, J.M. (1995) quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia, 9, 329-335.
20. Wasserman, R., Galili, N., Ito, Y., Silber, J.H., Reichard, B.A., Shane, S., Womer, R.B., Lange, B. & Rovera, G. (1992) Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. Journal of Clinical Oncology, 10, 1879-1888.
21. Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S.S., Lange, B., Tsujimoto, Y., Caton, A.J. & Rovera, G. (1989) Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proceedings of the National Academy of Sciences of the United States of America, 86, 5123-5127.
22. Yokota, S., Hansen-Hagge, T.E., Ludwig, W.D., Reiter, A., Raghavachar, A., Kleihauer, E. & Bartram, C.R. (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood, 77, 331-339.